TGA rejects demand for OTC oral contraceptives

The watchdog warned that women could miss out on preventive care such as cervical cancer screening

The latest bid for oral contraceptives to be sold over the counter in pharmacies has failed, with the TGA warning that women will miss out on HPV tests and other preventive health screening.

The regulator also stressed that the risk of adverse events associated with the substances such as venous thromboembolism and heavy bleeding confirmed the need for GP oversight.

In its final decision published last month, it said down-scheduling oral contraceptives “carries with it requirements for not only clinical screening,